FNY Partners Fund LP grew its stake in shares of Syneron Medical Ltd. (NASDAQ:ELOS) by 810.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,200 shares of the medical equipment provider’s stock after acquiring an additional 16,200 shares during the quarter. FNY Partners Fund LP’s holdings in Syneron Medical were worth $199,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of ELOS. Vivaldi Asset Management LLC acquired a new position in shares of Syneron Medical during the second quarter valued at about $9,644,000. SG Americas Securities LLC acquired a new position in shares of Syneron Medical during the second quarter valued at about $5,600,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in shares of Syneron Medical by 1,259.7% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 501,440 shares of the medical equipment provider’s stock valued at $5,491,000 after acquiring an additional 464,561 shares in the last quarter. Mizuho Securities USA LLC acquired a new position in shares of Syneron Medical during the second quarter valued at about $5,037,000. Finally, State of Wisconsin Investment Board acquired a new position in shares of Syneron Medical during the second quarter valued at about $3,504,000. Hedge funds and other institutional investors own 69.17% of the company’s stock.

Syneron Medical Ltd. (NASDAQ:ELOS) remained flat at $11.00 during trading on Wednesday. 3,905 shares of the stock traded hands. The company has a 50 day moving average of $10.90 and a 200 day moving average of $10.14. Syneron Medical Ltd. has a 52 week low of $6.18 and a 52 week high of $11.43.

WARNING: This article was first reported by Daily Political and is the property of of Daily Political. If you are viewing this article on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.dailypolitical.com/2017/09/13/syneron-medical-ltd-elos-stake-boosted-by-fny-partners-fund-lp.html.

Separately, BidaskClub downgraded shares of Syneron Medical from a “hold” rating to a “sell” rating in a report on Thursday, July 6th.

Syneron Medical Profile

Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments.

Want to see what other hedge funds are holding ELOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Syneron Medical Ltd. (NASDAQ:ELOS).

Institutional Ownership by Quarter for Syneron Medical (NASDAQ:ELOS)

Receive News & Ratings for Syneron Medical Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneron Medical Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.